Evaluation of 131I-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma
Panpan Hao(Ningxia Medical University), Guihua Hou(Yancheng Institute of Technology)
Cited by 7
Related Papers
Angiotensin-(1–1) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor
|Molecular Medicine|2015|53
TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
|Cell Death and Disease|2019|39